Elimination of babesia microti is dependent on intraerythrocytic killing and CD4+ T cells

Journal of Immunology

Volumn 199, Issue 2, 2017, Pages 633-642

  Skariah, Sini ^a   Arnaboldi, Paul ^b,c   Dattwyler, Raymond J ^b,c   Sultan, Ali A ^a   Gaylets, Corey ^b   Walwyn, Odaelys ^b   Mulhall, Hannah ^b   Wu, Xia ^b   Dargham, Soha R ^a   Mordue, Dana G ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c Biopeptides Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BABESIA MICROTI; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RESPONSE; ERYPTOSIS; INFECTION CONTROL; INTRACELLULAR SIGNALING; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PARASITE CLEARANCE; PARASITE TRANSMISSION; PIROPLASMOSIS; PRIORITY JOURNAL; RETICULOCYTOSIS; ANIMAL; BABESIOSIS; BAGG ALBINO MOUSE; BLOOD; BLOOD TRANSFUSION; C3H MOUSE; C57BL MOUSE; ERYTHROCYTE; HUMAN; IMMUNOLOGY; METABOLISM; PARASITEMIA; PARASITOLOGY; TRANSMISSION; UNITED STATES; ZOONOSIS;

ANIMALS; B-LYMPHOCYTES; BABESIA MICROTI; BABESIOSIS; BLOOD TRANSFUSION; CD4-POSITIVE T-LYMPHOCYTES; ERYTHROCYTES; HUMANS; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; PARASITEMIA; TOLL-LIKE RECEPTORS; UNITED STATES; ZOONOSES;

EID: 85023165259     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601193     Document Type: Article

References (46)

1. Lobo, C. A., J. R. Cursino-Santos, A. Alhassan, and M. Rodrigues. 2013. Babesia: an emerging infectious threat in transfusion medicine. PLoS Pathog. 9: e1003387.
2. U.S.Food and Drug Administration. 2014. Fatalities reported to FDA following blood collection and transfusion. Available at: http://www.fda.gov/ downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/ TransfusionDonationFatalities/UCM459461.pdf.
3. Conrad, P. A., A. M. Kjemtrup, R. A. Carreno, J. Thomford, K. Wainwright, M. Eberhard, R. Quick, S. R. Telford, III., and B. L. Herwaldt. 2006. Description of Babesia duncani sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int. J. Parasitol. 36: 779-789.
4. Vannier, E., and P. J. Krause. 2012. Human babesiosis. N. Engl. J. Med. 366: 2397-2407.
5. Rudzinska, M. A., W. Trager, S. J. Lewengrub, and E. Gubert. 1976. An electron microscopic study of Babesia microti invading erythrocytes. Cell Tissue Res. 169: 323-334.
6. Krause, P. J., B. E. Gewurz, D. Hill, F. M. Marty, E. Vannier, I. M. Foppa, R. R. Furman, E. Neuhaus, G. Skowron, S. Gupta, et al. 2008. Persistent and relapsing babesiosis in immunocompromised patients. Clin. Infect. Dis. 46: 370-376.
7. Krause, P. J., A. Spielman, S. R. Telford, III., V. K. Sikand, K. McKay, D. Christianson, R. J. Pollack, P. Brassard, J. Magera, R. Ryan, and D. H. Persing. 1998. Persistent parasitemia after acute babesiosis. N. Engl. J. Med. 339: 160-165.
8. Moritz, E. D., C. S. Winton, L. Tonnetti, R. L. Townsend, V. P. Berardi, M. E. Hewins, K. E. Weeks, R. Y. Dodd, and S. L. Stramer. 2016. Screening for Babesia microti in the U.S. blood supply. N. Engl. J. Med. 375: 2236-2245.
9. Leiby, D. A. 2011. Transfusion-associated babesiosis: shouldn't we be ticked off? Ann. Intern. Med. 155: 556-557.
10. Leiby, D. A. 2011. Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin. Microbiol. Rev. 24: 14-28.
11. Cursino-Santos, J. R., A. Alhassan, M. Singh, and C. A. Lobo. 2014. Babesia: impact of cold storage on the survival and the viability of parasites in blood bags. Transfusion 54: 585-591.
12. Gubernot, D. M., C. T. Lucey, K. C. Lee, G. B. Conley, L. G. Holness, and R. P. Wise. 2009. Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007. Clin. Infect. Dis. 48: 25-30.
13. Eberhard, M. L., E. M. Walker, and F. J. Steurer. 1995. Survival and infectivity of Babesia in blood maintained at 25 C and 2-4 C. J. Parasitol. 81: 790-792.
14. U.S. Food and Drug Administration. 2015. Issue summary for FDA Blood Products Advisory Committee. Available at: https://www.fda.gov/downloads/ advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/ bloodproductsadvisorycommittee/ucm446274.pdf. Accessed: May 31, 2017.
15. Gubernot, D. M., H. L. Nakhasi, P. A. Mied, D. M. Asher, J. S. Epstein, and S. Kumar. 2009. Transfusion-transmitted babesiosis in the United States: summary of a workshop. Transfusion 49: 2759-2771.
16. Clark, I. A., and A. C. Allison. 1974. Babesia microti and Plasmodium berghei yoelii infections in nude mice. Nature 252: 328-329.
17. Clawson, M. L., N. Paciorkowski, T. V. Rajan, C. La Vake, C. Pope, M. La Vake, S. K. Wikel, P. J. Krause, and J. D. Radolf. 2002. Cellular immunity, but not gamma interferon, is essential for resolution of Babesia microti infection in BALB/c mice. Infect. Immun. 70: 5304-5306.
18. Aguilar-Delfin, I., P. J. Wettstein, and D. H. Persing. 2003. Resistance to acute babesiosis is associated with interleukin-12-and gamma interferon-mediated responses and requires macrophages and natural killer cells. Infect. Immun. 71: 2002-2008.
19. Igarashi, I., R. Suzuki, S. Waki, Y. Tagawa, S. Seng, S. Tum, Y. Omata, A. Saito, H. Nagasawa, Y. Iwakura, et al. 1999. Roles of CD4(+) T cells and gamma interferon in protective immunity against Babesia microti infection in mice. Infect. Immun. 67: 4143-4148.
20. Van Peenen, P. F., and G. R. Healy. 1970. Infection of Microtus ochrogaster with piroplasms isolated from man. J. Parasitol. 56: 1029-1031.
21. Ruebush, M. J., and W. L. Hanson. 1979. Susceptibility of five strains of mice to Babesia microti of human origin. J. Parasitol. 65: 430-433.
22. Homer, M. J., I. Aguilar-Delfin, S. R. Telford, III., P. J. Krause, and D. H. Persing. 2000. Babesiosis. Clin. Microbiol. Rev. 13: 451-469.
23. Clark, I. A., J. E. Richmond, E. J. Wills, and A. C. Allison. 1977. Intraerythrocytic death of the parasite in mice recovering from infection with Babesia microti. Parasitology 75: 189-196.
24. Clark, I. A., E. J. Wills, J. E. Richmond, and A. C. Allison. 1977. Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition. Infect. Immun. 17: 430-438.
25. Clark, I. A., J. E. Richmond, E. J. Wills, and A. C. Allison. 1975. Immunity to intra-erythrocytic protoza. Lancet 2: 1128-1129.
26. Clark, I. A., A. C. Allison, and F. E. Cox. 1976. Protection of mice against Babesia and Plasmodium with BCG. Nature 259: 309-311.
27. Brecher, G. 1949. New methylene blue as a reticulocyte stain. Am. J. Clin. Pathol. 19: 895.
28. Riley, R. S., J. M. Ben-Ezra, R. Goel, and A. Tidwell. 2001. Reticulocytes and reticulocyte enumeration. J. Clin. Lab. Anal. 15: 267-294.
29. Hemmer, R. M., D. A. Ferrick, and P. A. Conrad. 2000. Role of T cells and cytokines in fatal and resolving experimental babesiosis: protection in TNFRp552/2 mice infected with the human Babesia WA1 parasite. J. Parasitol. 86: 736-742.
30. Jeong, Y. I., S. H. Hong, S. H. Cho, W. J. Lee, and S. E. Lee. 2012. Induction of IL-10-producing CD1dhighCD5+ regulatory B cells following Babesia microtiinfection. PLoS One 7: e46553.
31. Terkawi, M. A., S. Cao, M. S. Herbas, M. Nishimura, Y. Li, P. F. Moumouni, A. H. Pyarokhil, D. Kondoh, N. Kitamura, Y. Nishikawa, et al. 2015. Macrophages are the determinant of resistance to and outcome of nonlethal Babesia microti infection in mice. Infect. Immun. 83: 8-16.
32. Gowda, N. M., X. Wu, and D. C. Gowda. 2012. TLR9 and MyD88 are crucial for the development of protective immunity to malaria. J. Immunol. 188: 5073-5085.
33. Jason, J., L. K. Archibald, O. C. Nwanyanwu, M. G. Byrd, P. N. Kazembe, H. Dobbie, and W. R. Jarvis. 2001. Comparison of serum and cell-specific cytokines in humans. Clin. Diagn. Lab. Immunol. 8: 1097-1103.
34. Ghosh, S., S. A. Hoselton, and J. M. Schuh. 2012. m-Chain-deficient mice possess B-1 cells and produce IgG and IgE, but not IgA, following systemic sensitization and inhalational challenge in a fungal asthma model. J. Immunol. 189: 1322-1329.
35. McMorran, B. J., V. M. Marshall, C. de Graaf, K. E. Drysdale, M. Shabbar, G. K. Smyth, J. E. Corbin, W. S. Alexander, and S. J. Foote. 2009. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science 323: 797-800.
36. Love, M. S., M. G. Millholland, S. Mishra, S. Kulkarni, K. B. Freeman, W. Pan, R. W. Kavash, M. J. Costanzo, H. Jo, T. M. Daly, et al. 2012. Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials. Cell Host Microbe 12: 815-823.
37. McMorran, B. J., L. Wieczorski, K. E. Drysdale, J. A. Chan, H. M. Huang, C. Smith, C. Mitiku, J. G. Beeson, G. Burgio, and S. J. Foote. 2012. Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum. Science 338: 1348-1351.
38. Gramaglia, I., J. Velez, V. Combes, G. E. Grau, M. Wree, and H. C. van der Heyde. 2017. Platelets activate a pathogenic response to blood-stage Plasmodium infection but not a protective immune response. Blood 129: 1669-1679.
39. Okada, H., K. Suzue, T. Imai, T. Taniguchi, C. Shimokawa, R. Onishi, J. Hirata, and H. Hisaeda. 2015. A transient resistance to blood-stage malaria in interferongamma-deficient mice through impaired production of the host cells preferred by malaria parasites. Front. Microbiol. 6: 600.
40. Borggraefe, I., J. Yuan, S. R. Telford, III., S. Menon, R. Hunter, S. Shah, A. Spielman, J. A. Gelfand, H. H. Wortis, and E. Vannier. 2006. Babesia microti primarily invades mature erythrocytes in mice. Infect. Immun. 74: 3204-3212.
41. Bloch, E. M., A. E. Levin, P. C. Williamson, S. Cyrus, B. H. Shaz, D. Kessler, J. Gorlin, R. Bruhn, T. H. Lee, L. Montalvo, et al. 2016. A prospective evaluation of chronic Babesia microti infection in seroreactive blood donors. Transfusion 56: 1875-1882.
42. Raffalli, J., andG. P.Wormser. 2016. Persistence of babesiosis for .2 years in a patient on rituximab for rheumatoid arthritis. Diagn. Microbiol. Infect. Dis. 85: 231-232.
43. Cursino-Santos, J. R., M. Singh, P. Pham, M. Rodriguez, and C. A. Lobo. 2016. Babesia divergens builds a complex population structure composed of specific ratios of infected cells to ensure a prompt response to changing environmental conditions. Cell. Microbiol. 18: 859-874.
44. Ruebush, M. J., and W. L. Hanson. 1980. Transfer of immunity to Babesia microti of human origin using T lymphocytes in mice. Cell. Immunol. 52: 255-265.
45. Ruebush, M. J., and W. L. Hanson. 1980. Thymus dependence of resistance to infection with Babesia microti of human origin in mice. Am. J. Trop. Med. Hyg. 29: 507-515.
46. Aguilar-Delfin, I., M. J. Homer, P. J. Wettstein, and D. H. Persing. 2001. Innate resistance to Babesia infection is influenced by genetic background and gender. Infect. Immun. 69: 7955-7958.